ClinicalTrials.gg
Not yet recruitingNCT07186829FinXgerUpdated Oct 26, 2026

Repair of Extra-articular Fractures of the Metacarpals and First Phalanges of the Long Fingers

An interventional study of Percutaneous pinning and Locked plate in Hand Fractures, sponsored by University Hospital, Montpellier. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Treatment

How we know

Updated Oct 26, 2026Start date movedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 56 studies in Fractures, Bone with a site in France — 10 open to participants now, 13 under way, none of them phase 3. Fractures, Bone · France.

Planned enrollment
17th of 28
111 · median 130
Started
2026
with 1 other
No phase
19 of 56
4 open now
Primary completion
2027-12
later than 5 of 12 live
Registered
55th of 56
by date
Lead sponsor
2 of 56
University Hospital, Montpellier

Among the 56 studies in Fractures, Bone with a site in France, this one is the 17th largest by planned enrollment of the 28 interventional ones that give a count, is one of 2 that started in 2026, is one of 19 with no phase, reaches primary completion later than 5 of the 12 other live ones, and was the 55th registered.

Fractures, Bone

725 studies on the registry are indexed under Fractures, Bone; 116 are open to participants now.

Browse Fractures, Bone studies →

Open to participants now

10 of the 56 studies in Fractures, Bone with a site in France are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 73 Fractures, Bone studies recruiting now, 36 (49%) set no upper age limit and 23 (32%) stop at 75 or younger; 18 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Fractures, Bone with a site in France, or all of them as a file.
02

Study summary

The goal of this randomized controlled trial is to compare the effectiveness, complications, and cost-effectiveness of three surgical techniques (intramedullary screw fixation, locked plating, and percutaneous pinning) for treating simple transverse extra-articular fractures of the proximal phalanges and metacarpals (excluding the thumb) in adult patients. The main questions it aims to answer are:

The primary outcome is to define which technique results in better functional outcomes, as measured by pulp-to-palm distance at 6 weeks?

The main secondary outcome is to define which technique has lower complication rates and is more cost-effective over 12 months?

Participants will be randomly assigned to one of the three surgical techniques (intramedullary screw fixation, locked plating, or percutaneous pinning). Follow-up visits at weeks: 3, 6 and months: 3,6 and final follow-up at 12 months will assess hand function, range of motion, grip strength, radiographic healing, complications, satisfaction, and costs.

03

Conditions studied

  • Hand Fractures

Browse trials for

Keywords

  • hand
  • fracture
  • osteosynthesis
  • screw
  • plate
  • k-wire
  • phalanx
  • metacarpal
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Simple transverse extra-articular fractures of proximal or diaphyseal phalanges/metacarpals with surgical indication

Exclusion criteria

Exclusion Criteria:

  • Thumb fracture, open fracture, ischemia, pathological fracture, previous fracture, denial of consent
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
111 participants (estimated)

Study arms

  • Active comparator
    Percutaneous pinning

    closed reduction, two percutaneous pins

    Device: Percutaneous pinning

  • Active comparator
    Locked plate

    open reduction, dorsal approach, 3 screws proximal and distal

    Device: Locked plate

  • Active comparator
    Intramedullary screw

    1 cm dorsal incision, closed reduction, internal compression screw

    Device: Intramedullary screw

Interventions

  • DevicePercutaneous pinning

    Similar to arm - closed reduction, two percutaneous pins

    Also known as: K-wire, Kirchner wire

  • DeviceLocked plate

    Similar to arm - open reduction, dorsal approach, 3 screws proximal and distal

    Also known as: Locking plate

  • DeviceIntramedullary screw

    Similar to arm - 1 cm dorsal incision, closed reduction, internal compression screw

    Also known as: Intramedullary compression screw, Herbert screw

06

What researchers measure

Primary outcomes

  1. Pulp-to-palm distance at 6 weeks

    Global range of motion measured by pulp-to-palm distance at 6 weeks

    Time frame: at 6 weeks

Secondary outcomes

  1. Range of motion

    Flexion and extension angle in degrees for MCP and PIP joints

    Time frame: at 3 weeks, 6 weeks, 3months, 6 months and 12 months

  2. Bone Healing

    Radiographical bone healing with routine AP and lateral x-rays

    Time frame: 3weeks, 6 weeks, 3months, 6months, 12months

  3. Cost analysis of each technique at 12months

    Relative cost between each technique for intra and post operative care

    Time frame: 12months

  4. Complications

    Every clinical and paraclinical complication that may occur

    Time frame: 3weeks, 6 weeks, 3months, 6months, 12months

  5. Grip strength

    Grip strength measured in kg with a validated JAMAR® Hand Dynamometer

    Time frame: 3months, 6months, 12months

  6. QuickDASH PROM score

    Functional recovery evaluated with the QuickDASH PROM score

    Time frame: 3months, 6months, 12months

  7. Patient satisfaction

    Patient satisfaction evaluated with visual analogue scale (VAS)

    Time frame: 3months, 6months, 12months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.

Of 148 non-industry interventional studies with no phase under Fractures, Bone, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 57. This study's planned 12 months is below that.

Counting every sponsor, half of 166 studies reached it within 29 months; a quarter within 12 and three quarters within 57.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 26, 2026: start Nov 2025 → Dec 2026, primary completion Nov 2026 → Dec 2027 and completion Nov 2027 → Dec 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2025
First posted
Sep 22, 2025
StartEst.
Dec 15, 2026was Nov 2025
Primary completionEst.
Dec 15, 2027was Nov 2026
CompletionEst.
Dec 15, 2028was Nov 2027
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Nov 30, 2025→Dec 15, 2026
Oct 26, 2026
Primary completion
Nov 30, 2026→Dec 15, 2027
Oct 26, 2026
Study completion
Nov 30, 2027→Dec 15, 2028
Oct 26, 2026
Interventions
Changed Percutanous pinning→Percutaneous pinning. Arm changed Percutanous pinning→Percutaneous pinning
Oct 26, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionQuickDASH PROM score: how it is measured was reworded
Oct 26, 2026
Title
Randomised Controlled Evaluation of the Repair of Extra-articular Fractures of the Metacarpals and First Phalanges of the Long Fingers
Oct 26, 2026
Show all 1 update
  1. Oct 26, 2026
    Start date Nov 30, 2025→Dec 15, 2026
    Primary completion Nov 30, 2026→Dec 15, 2027
    Study completion Nov 30, 2027→Dec 15, 2028
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionQuickDASH PROM score: how it is measured was reworded
    Interventions Changed Percutanous pinning→Percutaneous pinning. Arm changed Percutanous pinning→Percutaneous pinning
    Title Randomised Controlled Evaluation of the Repair of Extra-articular Fractures of the Metacarpals and First Phalanges of the Long Fingers
    + 2 other changes: verification date and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07186829
Responsible party
Sponsor
First posted
Sep 22, 2025
Start date
Dec 15, 2026 (estimated)
Primary completion
Dec 15, 2027 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Oct 26, 2026

Study contacts

Pierre-Emmanuel Chammas, MD, MSc
Contact
pe-chammas@chu-montpellier.fr
+33467338537
Pierre-Emmanuel Chammas, MD, MSc
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion